Periodic Reporting for period 1 - FRAGMENTOME (FRAGMENT screening from advanced-sampling molecular dynamics simulations on a proteOME scale.)

Fragment-Based Lead Discovery (FBLD) is a mainstream strategy for the generation of new drugs. In FBLD highly sensitive biochemical and biophysical screening technologies are used to detect the low-affinity binding of low-molecular-weight compounds (the so-called fragments) to...